Position in DHR
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$63,523,393
-$31,562,190 QoQ
Shares Held
335,039
-19.3% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026DANSKE BANK A/S holds $320,359,923 across 16 Diagnostics & Research names. DHR ranks #2 (19.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
241,428 | $118,669,103 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
335,039 | $63,523,393 | |
| 3 | A |
Agilent Technologies, Inc.
|
248,991 | $28,379,993 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
44,067 | $24,760,806 | |
| 5 | DGX |
Quest Diagnostics Inc
|
69,961 | $13,710,956 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
76,066 | $12,972,294 | |
| 7 | WAT |
Waters Corp /De/
|
41,749 | $12,432,852 | |
| 8 | NTRA |
Natera, Inc.
|
54,302 | $10,859,856 |
All Filings in DHR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $63,523,393 | 335,039 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $95,085,583 | 415,366 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $73,697,603 | 371,722 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $79,564,370 | 402,776 | Shares | Sole | 2025-12-18 | |
| 2025-03-31 | $59,643,725 | 290,945 | Shares | Sole | 2025-12-18 | |
| 2024-12-31 | $78,338,297 | 341,269 | Shares | Sole | 2026-03-18 | |
| 2024-09-30 | $86,560,135 | 311,345 | Shares | Sole | 2026-03-18 | |
| 2024-06-30 | $83,289,745 | 333,359 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $104,172,695 | 417,158 | Shares | Sole | 2026-03-18 | |
| No filing history on record for this holder in this stock. | ||||||